Dr. Sarah Carratt is currently a postdoctoral fellow at Oregon Health & Science University, where she is researching leukemia initiation and progression.
Dr. Carratt earned her PhD in Pharmacology and Toxicology at the University of California, Davis under the mentorship of Dr. Laura Van Winkle, a respiratory toxicologist. As a graduate student, she worked on large toxicity studies and investigated the mechanisms of chemical carcinogenesis. Her dissertation investigated the metabolism and inhalation toxicity of naphthalene, a possible human carcinogen that is known to cause respiratory toxicity in adult rodents when bioactivated by cytochrome P450 enzymes (CYPs).
To complement her toxicology training and augment her existing research experience in mechanisms of carcinogenesis, Dr. Carratt chose to pursue a postdoctoral fellowship studying leukemia biology at Oregon Health & Science University. At OHSU, she mentored by Drs. Julia Maxson and Brian Druker—two people who have forged successful academic careers at the intersection of molecular biology and cancer therapeutics.
Dr. Carratt's long-term goal is to research mechanisms of carcinogenesis in a tenure-track faculty position, informing both risk management and therapeutic development.